Clinical Application of Oligonucleotide Probe Array for Full-Length Gene Sequencing of TP53 in Colon Cancer

Publisher： Karger

E-ISSN： 1423-0232|64|1|54-60

ISSN： 0030-2414

Source： Oncology, Vol.64, Iss.1, 2002-12, pp. : 54-60

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Tumor Suppressor Gene TP53: Implications for Cancer Management and Therapy

By Seemann Séverine   Maurici Daniela   Olivier Magali   Fromentel Claude   Hainaut Pierre  

Critical Reviews in Clinical Laboratory Sciences, Vol. 41, Iss. 5-6, 2004-09 ,pp. : 551-583

Informa Healthcare

Access to resources Recommend Favorite

Loss of TP53 in sarcomas with 17p12~p11 gain. A fine-resolution oligonucleotide array comparative genomic hybridization study

By  

Cytogenetic and Genome Research, Vol. 116, Iss. 3, 2007-02 ,pp. : 153-157

Karger

Access to resources Recommend Favorite

Alteration in Gene Expression Profile by Full-Length Hepatitis B Virus Genome

By  

Intervirology, Vol. 48, Iss. 2-3, 2005-03 ,pp. : 77-83

Karger

Access to resources Recommend Favorite

Genomic full‐length sequence of two HLA‐A alleles, A*23:01:01 and A*24:02:01:01, identified by cloning and sequencing

By  

HLA, Vol. 87, Iss. 1, 2016-01 ,pp. : 43-45

John Wiley & Sons Inc

Access to resources Recommend Favorite

Genomic full‐length sequence of two HLA‐A alleles, A*24:03:01 and A*24:07:01, identified by cloning and sequencing

By  

HLA, Vol. 87, Iss. 1, 2016-01 ,pp. : 46-48

John Wiley & Sons Inc

Access to resources Recommend Favorite